MER Indicator |
MER description |
Target Fiscal Year |
Target |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2016 |
650 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2016 |
673 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2016 |
3,773 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
7,768 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
12,864 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
12,864 |
CARE_NEW |
Aggregated Age/sex: <15 Female |
2016 |
30 |
CARE_NEW |
Aggregated Age/sex: <15 Male |
2016 |
62 |
CARE_NEW |
Aggregated Age/sex: 15+ Female |
2016 |
291 |
CARE_NEW |
Aggregated Age/sex: 15+ Male |
2016 |
655 |
CARE_NEW |
Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
1,038 |
CARE_NEW |
Sum of Aggregated Age/sex disaggregates |
2016 |
1,038 |
CARE_NEW |
Sum of Aggregated Age/sex disaggregates |
2016 |
1,038 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2016 |
293 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2016 |
293 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2016 |
78,880 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
3,188 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
7,420 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2016 |
15,803 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2016 |
86,886 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2016 |
586 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2016 |
15,803 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2016 |
86,300 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2016 |
15,803 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2016 |
86,886 |
KP_MAT |
Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months |
2016 |
1,050 |
KP_MAT |
Sex: Female |
2016 |
54 |
KP_MAT |
Sex: Male |
2016 |
996 |
KP_MAT |
Sum of Sex disaggregates |
2016 |
1,050 |
KP_PREV |
By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2016 |
5,191 |
KP_PREV |
By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2016 |
280 |
KP_PREV |
By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2016 |
5,264 |
KP_PREV |
By key population type: Men who have sex with men/Transgender (MSM/TG) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2016 |
1,152 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2016 |
11,886 |
LAB_CAP |
By clinical laboratories |
2016 |
12 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2016 |
12 |
PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2016 |
594 |
PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2016 |
553 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2016 |
222 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2016 |
331 |
PMTCT_ARV |
Sum of New and Current disaggregates |
2016 |
553 |
PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2016 |
586 |
PMTCT_STAT |
By: Known positives at entry |
2016 |
451 |
PMTCT_STAT |
By: Number of new positives identified |
2016 |
143 |
PMTCT_STAT |
Number of new ANC and L&D clients |
2016 |
7,100 |
PMTCT_STAT |
Number of new ANC and L&D clients |
2016 |
124,700 |
PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2016 |
7,100 |
PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2016 |
124,700 |
PMTCT_STAT |
Sum of Positives Status disaggregates |
2016 |
594 |
TB_SCREEN |
Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 |
2016 |
1,295 |
TB_SCREEN |
Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ |
2016 |
11,313 |
TB_SCREEN |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
12,864 |
TB_SCREEN |
Sum of Aggregated Age disaggregates |
2016 |
12,608 |
TB_SCREEN |
The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period |
2016 |
12,608 |
TX_CURR |
Aggregated Age/Sex: <1 Female |
2016 |
6 |
TX_CURR |
Aggregated Age/Sex: <1 Male |
2016 |
14 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2016 |
3,625 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2016 |
7,598 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2016 |
12,489 |
TX_CURR |
Sum of Aggregated Age/Sex (<1 and 1-14) <15 |
2016 |
1,266 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2016 |
11,223 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
11,223 |
TX_NEW |
Aggregated Grouping by Age: <1 Male |
2016 |
14 |
TX_NEW |
Aggregated Grouping by Age/Sex: <1 Female |
2016 |
4 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2016 |
292 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2016 |
574 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2016 |
958 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2016 |
866 |